Satoru Matsuda1, Hiroya Takeuchi2,3, Hirofumi Kawakubo1, Kazumasa Fukuda1, Rieko Nakamura1, Koichi Suda1, Norihito Wada1, Yuko Kitagawa1. 1. Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. 2. Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. htakeuchi@a6.keio.jp. 3. Department of Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan. htakeuchi@a6.keio.jp.
Abstract
BACKGROUND: For resectable advanced esophageal cancer, a transthoracic esophagectomy following preoperative treatment is recognized as one of the standard treatments. Therefore, predictive markers which can be identified before surgery need to be established to identify patients with a poor prognosis. METHODS: We retrospectively reviewed 102 consecutive patients who underwent curative transthoracic esophagectomy following preoperative treatment in our institution between 2004 and 2013. Based on plasma fibrinogen and serum albumin levels, the pretreatment and preoperative fibrinogen and albumin score (FA score) were investigated and the prognostic significance of the FA score change was compared with RECIST. RESULTS: The patients were classified according to whether the FA score had remained unchanged or decreased (n = 77) or the FA score increased (n = 25). When the correlation between the response rate and change in the FA score was investigated, the response rate was significantly lower in the group with the increased FA score. In the survival analysis, patients in the increased FA score group exhibited a significantly worse recurrence-free survival (RFS) (P = 0.038). A multivariate analysis using the clinical stage and the change in the FA score as covariates revealed that a change in the FA score (HR 1.802; P = 0.047; 95% CI 1.008-3.221) was shown to be a significant independent predictive factor for RFS. CONCLUSIONS: A change in the FA score was shown to be an independent prognostic factor for postoperative recurrence in esophageal cancer patients who have undergone transthoracic esophagectomy following preoperative treatment.
BACKGROUND: For resectable advanced esophageal cancer, a transthoracic esophagectomy following preoperative treatment is recognized as one of the standard treatments. Therefore, predictive markers which can be identified before surgery need to be established to identify patients with a poor prognosis. METHODS: We retrospectively reviewed 102 consecutive patients who underwent curative transthoracic esophagectomy following preoperative treatment in our institution between 2004 and 2013. Based on plasma fibrinogen and serum albumin levels, the pretreatment and preoperative fibrinogen and albumin score (FA score) were investigated and the prognostic significance of the FA score change was compared with RECIST. RESULTS: The patients were classified according to whether the FA score had remained unchanged or decreased (n = 77) or the FA score increased (n = 25). When the correlation between the response rate and change in the FA score was investigated, the response rate was significantly lower in the group with the increased FA score. In the survival analysis, patients in the increased FA score group exhibited a significantly worse recurrence-free survival (RFS) (P = 0.038). A multivariate analysis using the clinical stage and the change in the FA score as covariates revealed that a change in the FA score (HR 1.802; P = 0.047; 95% CI 1.008-3.221) was shown to be a significant independent predictive factor for RFS. CONCLUSIONS: A change in the FA score was shown to be an independent prognostic factor for postoperative recurrence in esophageal cancerpatients who have undergone transthoracic esophagectomy following preoperative treatment.
Authors: Katrin M Sjoquist; Bryan H Burmeister; B Mark Smithers; John R Zalcberg; R John Simes; Andrew Barbour; Val Gebski Journal: Lancet Oncol Date: 2011-06-16 Impact factor: 41.316
Authors: S Matsuda; H Takeuchi; K Fukuda; R Nakamura; T Takahashi; N Wada; H Kawakubo; Y Saikawa; T Omori; Y Kitagawa Journal: Dis Esophagus Date: 2013-08-27 Impact factor: 3.429
Authors: C Perisanidis; A Psyrri; E E Cohen; J Engelmann; G Heinze; B Perisanidis; A Stift; M Filipits; G Kornek; E Nkenke Journal: Cancer Treat Rev Date: 2015-12 Impact factor: 12.111
Authors: Eric Camerer; Aisha A Qazi; Daniel N Duong; Ivo Cornelissen; Rommel Advincula; Shaun R Coughlin Journal: Blood Date: 2004-03-18 Impact factor: 22.113
Authors: Glenys A Tennent; Stephen O Brennan; Arie J Stangou; John O'Grady; Philip N Hawkins; Mark B Pepys Journal: Blood Date: 2006-11-02 Impact factor: 22.113
Authors: Daniel Holzinger; Ivan Danilovic; Rudolf Seemann; Gabriela Kornek; Johannes Engelmann; Robert Pillerstorff; Simone Holawe; Amanda Psyrri; Boban M Erovic; Gregory Farwell; Christos Perisanidis Journal: PLoS One Date: 2016-06-30 Impact factor: 3.240